Filing Details
- Accession Number:
- 0001209191-19-006638
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-02-01 20:34:33
- Reporting Period:
- 2019-01-31
- Accepted Time:
- 2019-02-01 20:34:33
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 897448 | Amarin Corp Plc | AMRN | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1408920 | T Joseph Kennedy | C/O Amarin Pharma, Inc. 1430 Route 206 Bedminster NJ 07921 | General Counsel | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Acquisiton | 2019-01-31 | 1,953 | $1.02 | 1,953 | No | 4 | M | Direct | |
| Ordinary Shares | Acquisiton | 2019-01-31 | 2,604 | $1.40 | 4,557 | No | 4 | M | Direct | |
| Ordinary Shares | Acquisiton | 2019-01-31 | 18,749 | $2.50 | 23,306 | No | 4 | M | Direct | |
| Ordinary Shares | Acquisiton | 2019-01-31 | 3,437 | $2.95 | 26,743 | No | 4 | M | Direct | |
| Ordinary Shares | Acquisiton | 2019-01-31 | 2,437 | $3.80 | 29,180 | No | 4 | M | Direct | |
| Ordinary Shares | Acquisiton | 2019-01-31 | 26,666 | $0.00 | 55,846 | No | 4 | M | Direct | |
| Ordinary Shares | Acquisiton | 2019-01-31 | 36,000 | $0.00 | 91,846 | No | 4 | M | Direct | |
| Ordinary Shares | Acquisiton | 2019-01-31 | 26,000 | $0.00 | 117,846 | No | 4 | M | Direct | |
| Ordinary Shares | Disposition | 2019-01-31 | 43,962 | $16.94 | 73,884 | No | 4 | F | Direct | |
| Ordinary Shares | Disposition | 2019-01-31 | 42,624 | $17.49 | 31,260 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Ordinary Shares | Stock Option (Right to Buy) | Disposition | 2019-01-31 | 1,953 | $0.00 | 1,953 | $1.02 |
| Ordinary Shares | Stock Option (Right to Buy) | Disposition | 2019-01-31 | 2,604 | $0.00 | 2,604 | $1.40 |
| Ordinary Shares | Stock Option (Right to Buy) | Disposition | 2019-01-31 | 18,749 | $0.00 | 18,749 | $2.50 |
| Ordinary Shares | Stock Option (Right to Buy) | Disposition | 2019-01-31 | 3,437 | $0.00 | 3,437 | $2.95 |
| Ordinary Shares | Stock Option (Right to Buy) | Disposition | 2019-01-31 | 2,437 | $0.00 | 2,437 | $3.80 |
| Ordinary Shares | Restricted Stock Units | Disposition | 2019-01-31 | 26,666 | $0.00 | 26,666 | $0.00 |
| Ordinary Shares | Restricted Stock Units | Disposition | 2019-01-31 | 36,000 | $0.00 | 36,000 | $0.00 |
| Ordinary Shares | Restricted Stock Units | Disposition | 2019-01-31 | 26,000 | $0.00 | 26,000 | $0.00 |
| Ordinary Shares | Restricted Stock Units | Acquisiton | 2019-02-01 | 38,200 | $0.00 | 38,200 | $0.00 |
| Ordinary Shares | Stock Option (Right to Buy) | Acquisiton | 2019-02-01 | 53,500 | $0.00 | 53,500 | $16.88 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2025-02-01 | No | 4 | M | Direct | |
| 31,250 | 2026-01-31 | No | 4 | M | Direct | |
| 93,762 | 2025-07-06 | No | 4 | M | Direct | |
| 82,500 | 2027-02-01 | No | 4 | M | Direct | |
| 87,750 | 2028-02-01 | No | 4 | M | Direct | |
| 0 | No | 4 | M | Direct | ||
| 36,000 | No | 4 | M | Direct | ||
| 52,000 | No | 4 | M | Direct | ||
| 38,200 | No | 4 | A | Direct | ||
| 53,500 | 2029-02-01 | No | 4 | A | Direct |
Footnotes
- Multiple reportable transactions are reported in the Form 4 including grants of options, grants of restricted stock units, exercise of previously granted options, vesting of previously granted restricted stock units and sale of certain shares. The market sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.
- The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
- Please see the section titled "Remarks" below for additional information.
- On February 1, 2016, the Reporting Person was granted 80,000 Restricted Stock Units ("RSUs") under the Amarin Corporation plc 2011 Stock Incentive Plan (the "Plan"). These RSUs vest in three equal installments on each of January 31, 2017, January 31, 2018 and January 31, 2019. The third and final vesting event occurred on January 31, 2019.
- Not applicable.
- On February 1, 2017, the Reporting Person was granted 108,000 RSUs under the Plan. These RSUs vest in three equal installments on each of January 31, 2018, January 31, 2019 and January 31, 2020. The second vesting event occurred on January 31, 2019.
- On February 1, 2018, the Reporting Person was granted 78,000 RSUs under the Plan. These RSUs vest in three equal installments on each of January 31, 2019, January 31, 2020 and January 31, 2021. The first vesting event occurred on January 31, 2019.
- Represents withholding by the Issuer of shares in respect of tax liability incident to the vesting of a security issued in accordance with Rule 16b-3, and not a market sale of securities.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.05 to $17.96, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- On February 2, 2015, the Reporting Person was granted an option to purchase 93,750 Ordinary Shares under the Plan. The shares subject to this option shall vest and become exercisable in 48 equal monthly installments on the last day of each month that started on February 28, 2015.
- On February 1, 2016, the Reporting Person was granted an option to purchase 125,000 Ordinary Shares under the Plan. The shares subject to this option shall vest and become exercisable in 48 equal monthly installments on the last day of each month that started on February 29, 2016.
- On July 6, 2015, the Reporting Person was granted an option to purchase 900,000 Ordinary Shares under the Plan. The shares subject to this option shall vest and become exercisable in 48 equal monthly installments on the last day of each month that started on July 31, 2015.
- On February 1, 2017, the Reporting Person was granted an option to purchase 165,000 Ordinary Shares under the Plan. The shares subject to this option shall vest and become exercisable in 48 equal monthly installments on the last day of each month that started on February 28, 2017.
- On February 1, 2018, the Reporting Person was granted an option to purchase 117,000 Ordinary Shares under the Plan. The shares subject to this option shall vest and become exercisable in 48 equal monthly installments on the last day of each month that started on February 28, 2018.
- Each RSU represents a contingent right to receive one Ordinary Share or cash in lieu thereof at the Issuer's discretion.
- On February 1, 2019, the Reporting Person was granted 38,200 RSUs under the Plan. These RSUs vest in three equal installments on each of January 31, 2020, January 31, 2021 and January 31, 2022.
- On February 1, 2019, the Reporting Person was granted an option to purchase 53,500 Ordinary Shares under the Plan. The shares subject to this option shall vest and become exercisable in 16 equal quarterly installments starting on May 15, 2019.
Billionaire Hedge Funds
